I do this all the time, he told investigators—then the vials were found
En los márgenes donde la ciencia y la ley se encuentran, dos virólogos del gobierno estadounidense fueron detenidos en Detroit al regresar del Congo con muestras de mpox no declaradas, desafiando los protocolos que existen precisamente para proteger al público que su trabajo pretende servir. El incidente, ocurrido en enero pero revelado esta semana, pone en tensión la confianza depositada en las instituciones científicas federales y recuerda que ningún propósito —por legítimo que sea— justifica la elusión de las salvaguardas colectivas. La pregunta que queda suspendida no es solo legal, sino moral: ¿cuándo la familiaridad con el riesgo se convierte en indiferencia ante él?
- Dos científicos de alto perfil del Laboratorio Rocky Mountain fueron arrestados al intentar ingresar al país con viales de mpox inactivado sin los permisos ni la documentación exigidos por ley.
- Cuando los agentes los interrogaron, Munster negó categóricamente llevar materiales biológicos, afirmando que 'lo hace todo el tiempo', una declaración que el FBI calificó de sustancialmente falsa.
- Aunque las muestras estaban inactivadas y no representaban un riesgo infeccioso directo, la ocultación deliberada de materiales biológicos sacudió a las autoridades como una violación grave de la confianza pública y la bioseguridad.
- Funcionarios del Inspector General del Departamento de Salud advirtieron que el contrabando intencional de agentes biológicos sin autorización podría haber puesto en peligro al público, independientemente del estado de las muestras.
- Ambos científicos enfrentan cargos federales por contrabando de materiales biológicos y declaraciones falsas, con una comparecencia ante un juez federal en Montana como próximo paso del proceso.
Dos virólogos del gobierno federal estadounidense fueron arrestados en el Aeropuerto Metropolitano de Detroit en enero, tras regresar de nueve días en la República Democrática del Congo con viales de mpox inactivado que no declararon ante las autoridades aduaneras. Vincent Munster, jefe de la sección de ecología viral del Laboratorio Rocky Mountain en Hamilton, Montana, y su colega Claude Kwe enfrentan ahora cargos federales que se hicieron públicos esta semana.
Cuando los investigadores los interrogaron en el aeropuerto, Munster negó llevar cualquier material biológico y aseguró que tenía la documentación necesaria en su laptop, aunque insistió en que no la necesitaba. "Lo hago todo el tiempo", declaró, según el relato del FBI. Sin embargo, el examen posterior reveló que ambos transportaban muestras sin los permisos requeridos para el traslado internacional de agentes biológicos.
Funcionarios del Inspector General del Departamento de Salud y Servicios Humanos describieron el presunto contrabando como una ruptura de la confianza pública. Aunque las muestras estaban inactivadas y no representaban una amenaza infecciosa directa, la elusión deliberada de los protocolos de bioseguridad fue considerada una infracción grave. Los documentos judiciales no explican qué motivó a los científicos a saltarse los procedimientos establecidos.
El caso llega en un contexto más amplio: el mpox, antes conocido como viruela del mono, pasó de ser una enfermedad endémica en África central y occidental a desencadenar brotes en más de setenta países en 2022. Ambos científicos, con amplia experiencia en la investigación del virus, deberán comparecer ante un juez federal en Missoula. Lo que aún no queda claro es si actuaron por negligencia, por considerar los trámites innecesariamente engorrosos, o por alguna otra razón que el proceso judicial deberá dilucidar.
Two virologists employed at a federal research facility in Montana were arrested at Detroit Metropolitan Airport in January after returning from central Africa with undeclared biological samples, according to court documents made public this week. Vincent Munster, who heads the viral ecology section at Rocky Mountain Laboratories in Hamilton, and his colleague Claude Kwe had spent nine days in the Democratic Republic of Congo before boarding a flight through Paris back to the United States. What they carried with them—vials of inactivated mpox virus—would become the subject of a federal criminal complaint filed in Detroit.
When questioned by investigators at the airport, Munster denied bringing any biological materials or samples into the country. He told agents that all necessary documentation was on his laptop, but insisted he didn't need it. "I do this all the time," he said, according to the FBI's account. The denial was categorical and unequivocal. Yet subsequent examination revealed the truth: both men were traveling with mpox samples that had been rendered inactive, or disabled. They had neither declared the materials nor obtained the permits required by law to transport such biological agents across international borders.
The violation struck at something officials described as fundamental. Marcus Sykes, from the Inspector General's office at the Department of Health and Human Services, characterized the alleged smuggling as a breach of public trust. Any deliberate attempt to conceal and illegally import biological materials without proper authorization, he stated, could have endangered the public. The samples themselves were inactivated—meaning they posed no direct infectious threat—but the act of concealment and the circumvention of biosecurity protocols remained serious infractions.
Munster and Kwe are both experienced virologists with substantial backgrounds in mpox research. The court documents filed by prosecutors do not explain what motivated them to bring the samples back to their laboratory without following established procedures. Neither scientist responded immediately to requests for comment. Both were expected to appear before a federal judge in Missoula, Montana, on a Wednesday following the public disclosure of charges.
The incident raises questions about oversight within government research institutions and the protocols meant to govern the movement of dangerous biological materials. Mpox, formerly known as monkeypox, was first identified in 1958 during disease outbreaks in laboratory primates. For decades, human cases remained concentrated in central and western Africa among people with direct contact to infected animals. That changed in 2022, when the virus began spreading through sexual transmission and sparked outbreaks across more than seventy countries with no prior history of the disease. The virus can cause rash and fever in most cases, though severe illness is possible. Most people recover fully.
The FBI's assessment of Munster's statements was direct: his claims to customs officials about possessing required documentation were substantially false. The agency's investigation found no legitimate justification for the undeclared transport. What remains unclear is whether this was an act of negligence, a deliberate circumvention of rules the scientists viewed as burdensome, or something else entirely. The case now moves through the federal court system, with both men facing charges related to smuggling biological materials and making false statements to government investigators.
Citas Notables
Any deliberate attempt to conceal and introduce biological materials without proper authorization constitutes a violation of public trust and could have endangered citizens— Marcus Sykes, Inspector General's office, Department of Health and Human Services
La Conversación del Hearth Otra perspectiva de la historia
Why would two experienced virologists risk their careers and freedom to bring samples back without permission?
The documents don't say. That's the puzzle. They had the expertise to know the rules. Munster even claimed he did this routinely. Maybe he thought the inactivation made it harmless enough to skip the paperwork. Or maybe there was something about their research they wanted to continue outside normal channels.
But the samples were inactive. Wasn't that the whole point—no actual danger?
Danger isn't the only issue. It's about control. Governments track biological materials for a reason. If two scientists can walk samples through an airport without declaring them, the entire system breaks down. The inactivation matters for public health, but the breach of protocol matters for institutional trust.
What happens now?
They face federal charges. A court appearance in Montana. The real question is whether this was isolated negligence or part of a pattern. And whether their laboratory knew what they were doing.
Did the lab know?
The documents don't indicate that. But that's another investigation waiting to happen. If the lab didn't know, that's a management failure. If it did, that's much worse.
What does this tell us about biosecurity at American research institutions?
That the rules exist on paper, but enforcement depends on people following them. Two scientists with credentials and experience thought they could skip the process. They almost got away with it. That should worry people.